Cargando…

Comparison of Two Antiretroviral Therapy Regimens in Human Immunodeficiency Virus (HIV−) Infected Pregnant Women

BACKGROUND: Combined antiretroviral therapy (cART) in human immunodeficiency virus (HIV)-infected pregnant women reduces the maternal-to-child transmission (MTCT) rate from a baseline of 25% to less than 2% when the HIV viral load (VL) is <1,000 copies/mL. The traditional cART is composed of 2 nu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tate, Danielle, Samson, Fernand, Christiansen, Mary, Meyers, Lindsay, Cashion, Kitty, Wang, Jenny, Cruz, Marina Santa, Gomez, Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630893/ http://dx.doi.org/10.1093/ofid/ofx163.1767

Ejemplares similares

Treatment outcome of different antiretroviral drug regimens in HIV-positive pregnant women
por: Chauhan, Nidhi, et al.
Publicado: (2021)

Adherence to antiretroviral treatment regimens and correlation with risk of hospitalization among commercially insured HIV patients in the US
por: Sax, PE, et al.
Publicado: (2010)

Towards an ideal antiretroviral regimen for the global HIV epidemic
por: Grinsztejn, Beatriz, et al.
Publicado: (2017)

The impact of HBV or HCV infection in a cohort of HIV-infected pregnant women receiving a nevirapine-based antiretroviral regimen in Malawi
por: Andreotti, Mauro, et al.
Publicado: (2014)

Antiretroviral Regimen and Suboptimal Medication Adherence Are Associated With Low-Level Human Immunodeficiency Virus Viremia
por: Konstantopoulos, Christina, et al.
Publicado: (2015)

Effectiveness of four antiretroviral regimens for treating people living with HIV
por: Cavalcanti, Aracele Tenório de Almeida e, et al.
Publicado: (2020)

Effect of highly active antiretroviral therapy (HAART) on some specific clotting profile in Human Immunodeficiency Virus -(HIV) positive pregnant women
por: Evarista, Osime Odaburhine, et al.
Publicado: (2020)

Subacute sclerosing panencephalitis in a child with human immunodeficiency virus (HIV) infection on antiretroviral therapy
por: Muthusamy, Karthik, et al.
Publicado: (2015)

Depression in HIV-positive women is associated with changes in antiretroviral treatment regimens
por: Philippe Küpper-Tetzel, Claus, et al.
Publicado: (2014)

Assessment of Noninvasive Markers of Steatosis and Liver Fibrosis in Human Immunodeficiency Virus-Monoinfected Patients on Stable Antiretroviral Regimens
por: Busca, C, et al.
Publicado: (2022)

Fibrinolytic changes in pregnant women on highly active antiretroviral therapy
por: Osime, Odaburhine E., et al.
Publicado: (2015)

Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens
por: De La Cruz, Justin, et al.
Publicado: (2019)

Desimplification to multi-tablet antiretroviral regimens in human immunodeficiency virus-type 1 infected adults: A cohort study
por: Rossi, Maria C, et al.
Publicado: (2019)

Clinical and paraclinical aspects of HIV infected patients with first-line antiretroviral regimens
por: Bîstrițchi, Ina, et al.
Publicado: (2013)

Patients’ willingness to take separate component antiretroviral therapy regimens for HIV in the Netherlands
por: Engelhard, Esther, et al.
Publicado: (2014)

Fecal Bacterial Communities in treated HIV infected individuals on two antiretroviral regimens
por: Pinto-Cardoso, Sandra, et al.
Publicado: (2017)

Patients’ Willingness to Take Multiple-Tablet Antiretroviral Therapy Regimens for Treatment of HIV
por: Engelhard, Esther A. N., et al.
Publicado: (2016)

Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults
por: DeJesus, Edwin, et al.
Publicado: (2019)

Dolutegravir: Virologic response and tolerability of initial antiretroviral regimens for adults living with HIV
por: Correa, Analú, et al.
Publicado: (2020)

Trends in Antiretroviral Regimen Complexity Among Medicare Beneficiaries With HIV, 2014-2018
por: Fleming, Sean, et al.
Publicado: (2021)

Human Immunodeficiency Virus (HIV)–Infected CCR6(+) Rectal CD4(+) T Cells and HIV Persistence On Antiretroviral Therapy
por: Anderson, Jenny L, et al.
Publicado: (2020)

Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection
por: Kiweewa, Flavia Matovu, et al.
Publicado: (2022)

Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons
por: Brunet, Laurence, et al.
Publicado: (2016)

Antiretroviral Therapy Containing Raltegravir to Prevent Mother-to-Child Transmission of HIV in Infected Pregnant Women
por: Cecchini, Diego M., et al.
Publicado: (2017)

Combination Antiretroviral Therapy and Immunophenotype of Feline Immunodeficiency Virus
por: Kim, Jeffrey, et al.
Publicado: (2023)

Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi
por: Tweya, Hannock, et al.
Publicado: (2014)

Comparative efficacy and safety of regimens including ritonavir-boosted lopinavir or nevirapine in antiretroviral-naïve HIV-1-infected individuals
por: Pereira, A, et al.
Publicado: (2010)

Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in Africa
por: Ciaffi, Laura, et al.
Publicado: (2015)

Modification of Initial Highly Active Antiretroviral Therapy (HAART) Regimen in Paediatric HIV Patients
por: Low, Yee Shan, et al.
Publicado: (2018)

Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings
por: Cattaneo, Dario, et al.
Publicado: (2020)

Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1–Infected Adults in the United States
por: Mukerji, Shibani S, et al.
Publicado: (2018)

557. Evaluation of Clinical Response of a Two Tablet Once Daily Antiretroviral Regimen in Antiretroviral Experienced HIV-Infected Patients
por: Maki, Gina, et al.
Publicado: (2018)

Persistent Immune Activation in Human Immunodeficiency Virus–Infected Pregnant Women Starting Combination Antiretroviral Therapy After Conception
por: Lohman-Payne, Barbara, et al.
Publicado: (2021)

Clinically Significant Lower Elvitegravir Exposure During the Third Trimester of Pregnant Patients Living With Human Immunodeficiency Virus: Data From the Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Network
por: Bukkems, Vera, et al.
Publicado: (2020)

Brief Report: Vaginal Viral Shedding With Undetectable Plasma HIV Viral Load in Pregnant Women Receiving 2 Different Antiretroviral Regimens: A Randomized Clinical Trial
por: Frenkel, Lisa M., et al.
Publicado: (2021)

Antiretroviral regimen complexity as a predictor of adherence
por: Boyle, C, et al.
Publicado: (2010)

Comparison of Antiretroviral Regimens: Adverse Effects and Tolerability Failure that Cause Regimen Switching
por: Kim, Min Jung, et al.
Publicado: (2015)

135 HIV-associated immunodeficiency despite potent antiretroviral therapy with CD4 T cell reconstitution
por: Poonia, Bhawna, et al.
Publicado: (2014)

Antiretroviral therapy in pregnant women living with HIV: a clinical practice guideline
por: Siemieniuk, Reed A C, et al.
Publicado: (2017)

Outcome expectancies toward adherence to antiretroviral therapy for pregnant and postpartum women with HIV
por: Momplaisir, Florence M, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r3900re3vk7vs2k1huhrbf9arf